Chantez Sanford Jr., 24, of Southfield, says his life has been transformed after undergoing Lyfgenia gene therapy at Children ...
The last available hemophilia gene therapy is temporarily unavailable, according to CSL Behring. Hemgenix, CSL’s one-time gene therapy for patients with hemophilia B, is experiencing a “temporary ...
At just 24, Chantez "CJ" Sanford is quietly making Michigan medical history. He is the first person in the state to receive ...
An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and ...
Daniel Cressy says today is a life-changing day. The man in his 20s received a gene therapy transfusion Wednesday at Manning ...
A pioneering gene therapy could help treat a rare seizure disorder called Dravet syndrome, according to new clinical trial ...
Zacks Investment Research on MSN
SRPT stock up as enrollment begins in DMD gene therapy safety study
Shares of Sarepta Therapeutics SRPT rose about 2% yesterday after it announced that screening and enrollment are underway in ...
A 24-year-old Southfield college student has become the first patient in Michigan to receive a new gene therapy that could ...
Enh3ance trial results indicate DTX301 reduces ammonia levels by 18% and supports dietary liberalization in patients with OTC deficiency.
March 11 (Reuters) - Regenxbio said on Wednesday that interim data from a early-to-mid stage study of its experimental gene ...
Forbes contributors publish independent expert analyses and insights. A patient in a late-stage gene editing trial for a rare heart condition died from fatal liver complications after receiving an ...
MedPage Today on MSN
Cardiologist's Fake Cancer; Gene Therapy Trial Resumes; More Impella Woes
Recent developments of interest in cardiovascular medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results